Tobacco maker seeks new FDA label

Status
Not open for further replies.

banjo

Vaping Master
ECF Veteran
Verified Member
Jul 25, 2010
3,350
215
Rio Oso, CA
Last edited:

Placebo Effect

Ultra Member
ECF Veteran
Sep 19, 2008
1,444
1,562
Federal authorities say containing any carcinogens mean it's not a safe cigarette substitute,

Makes perfect sense.

Full AP Report

From Virginia Business

Star Scientific develops new snuff product with lower levels of carcinogens
January 04, 2011 12:44 PM

Star Scientific Inc. announced Tuesday that it has developed a moist snuff tobacco product with lower levels of carcinogens than other snuff products currently on the market.

The new product, Stonewall Moist-BDL, has levels of tobacco-specific nitrosamines (TSNAs) — recognized by scientists as one of the most powerful cancer-causing agents in tobacco leaf and smoke – below 20 parts per billion. The company said in a statement that that level is 99 percent lower than levels found in conventional American moist snuffs such as Copenhagen or Skoal, and 90 percent less than the level found in current “snus” products.

The development comes as the moist snuff products segment of the U.S. tobacco market continues to grow. Currently, it accounts for the largest portion of the smokeless tobacco market (73 percent). Plus, it has been the fastest-growing segment in recent years, with an annual rate of 4 to 7 percent.

“We knew we could make a snuff product that had hundreds of times lower toxin levels, since we already had pioneered this achievement with our BDL dissolvable smokeless products,” Paul L. Perito, chairman and president of Star Scientific, said in a press release. “We are proud of our continued leadership in innovation — it is clear that the means are available for all tobacco companies to reduce well-established toxins in the tobacco they use in manufacturing.”

The company, based in Henrico County, intends to submit an application for approval to market Stonewall Moist-BDL as a modified-risk tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009 during the first quarter of this year. Star Scientific submitted two modified-risk applications to the Federal Drug Administration in February and June of last year for approval for the company’s Ariva-BDL™ and Stonewall-BDL™ dissolvable smokeless products.

Star Scientific (Nasdaq:CIGX) is a technology-oriented company with a mission to reduce the harm associated with tobacco.
 

mpetva

Super Member
ECF Veteran
Apr 16, 2009
936
4
Virginia
Virginia tobacco maker seeks new FDA designation - Yahoo! News

Virginia tobacco maker seeks new FDA designation
By MICHAEL FELBERBAUM, AP Tobacco Writer Michael Felberbaum, Ap Tobacco Writer – Tue Jan 4, 8:15 am ET
RICHMOND, Va. – Tobacco maker Star Scientific Inc. says it has developed a moist smokeless tobacco with lower levels of cancer-causing chemicals than any other tobacco product now on the market.

The small Virginia company, which sells tobacco lozenges that dissolve in the mouth, said Tuesday it plans to soon ask the Food and Drug Administration for approval to sell the new item as safer than any competing product.

Star Scientific hopes its products will be the first the federal agency allows to be marketed as less harmful than other forms of tobacco.

Star Scientific says the "modified-risk" label that the FDA is developing belongs on the new Stonewall Moist-BDL because it contains 90 percent to 99 percent less tobacco-specific carcinogens than other smokeless tobacco products.

The federal Centers for Disease Control says that, because smokeless tobacco contains 28 cancer-causing agents, it is not a safe substitute for smoking cigarettes. But a 2007 report from the United Kingdom's Royal College of Physicians suggests that some smokeless tobacco products are less harmful than cigarettes.

Curtis Wright, senior vice president and clinical director for Star Scientific's subsidiary Rock Creek Pharmaceuticals, said the new product could "substantially" reduce the amount of carcinogens that moist tobacco users encounter.

The FDA is still considering similar applications from Star for two of its dissolvable tobacco products. Star has sold dissolvable tobacco under the Ariva and Stonewall brands since 2001.

The applications highlight a philosophical debate over how best to control tobacco. Some health advocates and officials say there's no safe way to use tobacco. Others say smokeless tobacco, electronic cigarettes and other products with lower levels of carcinogens than traditional tobacco products can improve public health by reducing the number of people who smoke.

Cigarette sales have been falling for years due to tax increases, health concerns, smoking bans and social stigma. Bigger tobacco companies are watching the FDA response to Star's applications for clues about what products they'll be able to sell to replace the revenue from cigarettes.

The FDA won the authority in 2009 to evaluate tobacco products and approve some as safer than others. But it may take the agency another year to iron out its guidelines for such products, and approvals would come only after guidelines are set.

About one in five Americans smoke, down from one out of four in 1995, according to the Centers for Disease Control and Prevention. About 3 percent of American adults use smokeless tobacco; the segment has grown about 7 percent in recent years.
 

Stubby

Ultra Member
ECF Veteran
Apr 22, 2009
2,104
1,992
Madison, WI USA
I thought "moist snuff" was the U.S. verbiage for "snus?"

That's true, but I'm not quite sure what star scientific is up to with there new product. I would have to assume in would be a ultra low TSNA version of snus.

Interesting history as US made snuff was originated by Swedish immigrants who missed there beloved snus. Of course a well known US brand of snuff is Copenhagen.
 

Bill Godshall

Executive Director<br/> Smokefree Pennsylvania
ECF Veteran
Apr 2, 2009
5,171
13,288
67
Star just announced that it has developed a new very low nitrosamine moist snuff product, and that it would soon apply to the FDA to approve the new product as a "modified risk tobacco product". That means the product is not being sold yet, and that it may need FDA's approval before it can be marketed (at least before it is marketed as a modified risk tobacco product).

Star has already submitted two previous applications to the FDA to market its Ariva and Stonewall (which are very low nitrosamine compressed dry snuff products, or dissolvable tobacco lozenges) as "modified risk tobacco products". But unlike Star's new product announcement, Star has been marketing Ariva and Stonewall as tobacco products for the past decade.

Per Kristin's inquiry, while snus is legally classified as "moist snuff" by the FSPTCA and by the federal tobacco excise tax law, many folks in the tobacco industry and in the public health community classify snus products (which are pasteurized) differently than American moist snuff products (which are fermented) including Skoal, Copenhagen, Grizzly, etc.

Also, Reynolds and Altria are target marketing their Camel Snus and Marlboro Snus products directly to smokers, despite the largely unknown fact that far more smokers have switched to (or engage in dual usage of) Skoal than snus.
 

Vocalek

CASAA Activist
Supporting Member
ECF Veteran
I guess that means that the Pharmaceutical produced NRTs aren't a safe substitute either? :D

Yup. Except for the fact that FDA is actively considering approval of "long-term use" of NRTs. I hope they do it. Then we can truthfully say, "No less safe than your nicotine gum."
 

StormFinch

Ultra Member
ECF Veteran
Verified Member
Mar 22, 2010
2,683
4,812
Arkansas
Yup. Except for the fact that FDA is actively considering approval of "long-term use" of NRTs. I hope they do it. Then we can truthfully say, "No less safe than your nicotine gum."

Right there with you. I mean, might as well approve something for long term use when most everyone using them is doing exactly that anyway, right? :facepalm:
 

kristin

ECF Guru
ECF Veteran
Aug 16, 2009
10,448
21,120
CASAA - Wisconsin
casaa.org
Right there with you. I mean, might as well approve something for long term use when most everyone using them is doing exactly that anyway, right? :facepalm:

LOL! (touches nose)

Actually, the reports say that almost 40% of gum/lozenge users use the products as a nicotine source (in lieu of tobacco) and not as a nicotine reduction/addiction treatment. Even so, bear in mind that 93% of people who use the products go right back to smoking. So, of the 7% who keep from smoking longer than 12 months, 40% of THOSE people use the products long term.

That says a lot about the true "effectiveness" of these products, doesn't it?
 
Status
Not open for further replies.

Users who are viewing this thread